-
Something wrong with this record ?
Caco-2 Cells, Biopharmaceutics Classification System (BCS) and Biowaiter
Libuše Smetanová, Věra Štětinová, Zbyněk Svoboda, Jaroslav Květina
Language English Country Czech Republic
Digital library NLK
Full text - Article
Issue
Volume
Source
Source
NLK
Directory of Open Access Journals
from 1997
Free Medical Journals
from 1997
Open Access Digital Library
from 1997-01-01
ROAD: Directory of Open Access Scholarly Resources
from 1997
- MeSH
- Biological Transport physiology drug effects MeSH
- Cell Culture Techniques MeSH
- Caco-2 Cells MeSH
- Diffusion MeSH
- Financing, Organized MeSH
- Intestinal Absorption MeSH
- Kinetics MeSH
- Caffeine pharmacokinetics pharmacology MeSH
- Hydrogen-Ion Concentration MeSH
- Humans MeSH
- Linear Models MeSH
- Mannitol metabolism MeSH
- Permeability drug effects MeSH
- Intestinal Mucosa metabolism MeSH
- Tight Junctions metabolism drug effects MeSH
- Cell Survival drug effects MeSH
- Xenobiotics pharmacokinetics pharmacology MeSH
- Check Tag
- Humans MeSH
The Caco-2 cell monolayer model is widely used as a standard screening tool for studying the mechanisms of cellular drug transport. Caffeine was chosen as a model drug and is supposed to be class I of the Biopharmaceutics Classification System (BCS). Our study was conducted 1) to characterize the mechanisms of caffeine transport across the intestinal barrier, 2) to classify caffeine according to BCS, 3) to predict drugs intestinal absorption in humans. METHODS: Caffeine transport (0.1, 0.3, 1 and 10 mmol/l) was studied in Caco-2 cell monolayer in apical to basolateral (AP-BL) and basolateral to apical (BL-AP) direction, under iso-pH 7.4 and pH-gradient (6/7.4) conditions. The relative contribution of the paracellular route was estimated using Ca2+- free transport medium (opening tight junctions). RESULTS: The caffeine transport was linear with time, transport direction and pH independent, displaying non-saturable (first-order) kinetics, with high permeability coefficient (Papp): in AP-BL direction Papp = 46.3-53.5 x 10-6 cm/s; in BL-AP direction Papp = 45.6-49.4 x 10-6 cm/s. Thus, the transport seems to be transcellular mediated by passive diffusion. Using Ca2+- free transport medium tight junctions were opened (confirmed by increased Papp of mannitol) but the caffeine Papp was not changed. Thus, the paracellular route is only a minor way of caffeine transport. CONCLUSION: High solubility and high permeability of caffeine rank it among class I of BCS and well absorbed compounds
References provided by Crossref.org
Lit.: 34
- 000
- 00000naa 2200000 a 4500
- 001
- bmc11008366
- 003
- CZ-PrNML
- 005
- 20111210203709.0
- 008
- 110428s2011 xr e eng||
- 009
- AR
- 024 7_
- $a 10.14712/18059694.2016.9 $2 doi
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Smetanová, Libuše $7 xx0139464
- 245 10
- $a Caco-2 Cells, Biopharmaceutics Classification System (BCS) and Biowaiter / $c Libuše Smetanová, Věra Štětinová, Zbyněk Svoboda, Jaroslav Květina
- 314 __
- $a Institute of Experimental Biopharmaceutics, Czech Academy of Sciences, Czech Republic. smetanova@uebf.cas.cz
- 504 __
- $a Lit.: 34
- 520 9_
- $a The Caco-2 cell monolayer model is widely used as a standard screening tool for studying the mechanisms of cellular drug transport. Caffeine was chosen as a model drug and is supposed to be class I of the Biopharmaceutics Classification System (BCS). Our study was conducted 1) to characterize the mechanisms of caffeine transport across the intestinal barrier, 2) to classify caffeine according to BCS, 3) to predict drugs intestinal absorption in humans. METHODS: Caffeine transport (0.1, 0.3, 1 and 10 mmol/l) was studied in Caco-2 cell monolayer in apical to basolateral (AP-BL) and basolateral to apical (BL-AP) direction, under iso-pH 7.4 and pH-gradient (6/7.4) conditions. The relative contribution of the paracellular route was estimated using Ca2+- free transport medium (opening tight junctions). RESULTS: The caffeine transport was linear with time, transport direction and pH independent, displaying non-saturable (first-order) kinetics, with high permeability coefficient (Papp): in AP-BL direction Papp = 46.3-53.5 x 10-6 cm/s; in BL-AP direction Papp = 45.6-49.4 x 10-6 cm/s. Thus, the transport seems to be transcellular mediated by passive diffusion. Using Ca2+- free transport medium tight junctions were opened (confirmed by increased Papp of mannitol) but the caffeine Papp was not changed. Thus, the paracellular route is only a minor way of caffeine transport. CONCLUSION: High solubility and high permeability of caffeine rank it among class I of BCS and well absorbed compounds
- 650 _2
- $a financování organizované $7 D005381
- 650 _2
- $a biologický transport $x fyziologie $x účinky léků $7 D001692
- 650 _2
- $a Caco-2 buňky $7 D018938
- 650 _2
- $a kofein $x farmakokinetika $x farmakologie $7 D002110
- 650 _2
- $a buněčné kultury $7 D018929
- 650 _2
- $a viabilita buněk $x účinky léků $7 D002470
- 650 _2
- $a difuze $7 D004058
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a koncentrace vodíkových iontů $7 D006863
- 650 _2
- $a intestinální absorpce $7 D007408
- 650 _2
- $a střevní sliznice $x metabolismus $7 D007413
- 650 _2
- $a kinetika $7 D007700
- 650 _2
- $a lineární modely $7 D016014
- 650 _2
- $a mannitol $x metabolismus $7 D008353
- 650 _2
- $a permeabilita $x účinky léků $7 D010539
- 650 _2
- $a těsný spoj $x metabolismus $x účinky léků $7 D019108
- 650 _2
- $a xenobiotika $x farmakokinetika $x farmakologie $7 D015262
- 700 1_
- $a Štětinová, Věra $7 xx0117623
- 700 1_
- $a Svoboda, Zbyněk $7 xx0081965
- 700 1_
- $a Květina, Jaroslav, $d 1930- $7 jk01071205
- 773 0_
- $w MED00010947 $t Acta medica (Hradec Králové) $g Roč. 54, č. 1 (2011), s. 3-8 $x 1211-4286
- 856 41
- $u https://actamedica.lfhk.cuni.cz/media/pdf/am_2011054010003.pdf $y plný text volně přístupný
- 910 __
- $a ABA008 $b A 3077 $c 1072 $y 1
- 990 __
- $a 20110428135242 $b ABA008
- 991 __
- $a 20111101114428 $b ABA008
- 999 __
- $a ok $b bmc $g 836275 $s 700566
- BAS __
- $a 3
- BMC __
- $a 2011 $b 54 $c 1 $d 3-8 $m Acta Medica $x MED00010947
- LZP __
- $a 2011-07/mkme